Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleClinical Practice

Secondary (AA) Amyloidosis with Development of Nephrotic Syndrome

Christopher W. Larrimore and Ezra Fox
American Society for Clinical Laboratory Science January 2017, 30 (1) 23-27; DOI: https://doi.org/10.29074/ascls.30.1.23
Christopher W. Larrimore
NOVA Southeastern University, College of Osteopathic Medicine, Davie, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cl1398{at}nova.edu
Ezra Fox
NOVA Southeastern University, College of Osteopathic Medicine, Davie, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Hematology and Chemistry Laboratory Results

    Analyte1AdmDay 1Day 22Ref Range
    Hematology
    Neutrophils69.670.269.838 – 70%
    Lymphocytes23.122.923.315 – 40%
    Monocytes5.65.45.22 – 11%
    Eosinophils1.21.01.20 – 6%
    Basophils0.50.50.50 – 2%
    RBC count5.95.75.94.7 – 6.1 × 1012/L
    Reticulocytes0.60.60.60.5 – 2.0%
    Platelets111119109150 – 400 × 109/L
    3Sed Rate2925180 – 15 mm/hr
    WBC Count1414134.8 – 10.8 × 109/L
    Hematocrit48494840 – 54%
    Hemoglobin17171714 – 18 g/dL
    Chemistry
    Creatinine3.13.53.00.6 – 1.2 mg/dL
    BUN2726265 – 25 mg/dL
    C-Reactive Protein4540210.5 mg/dL
    Serum Amyloid-A111105990.03 mg/dL
    Serum Albumin2.12.12.53.0 – 5.4 g/dL
    Additional Studies
    4ANA-Negative-Autoimmune Marker
    HLA-B27-Positive-Ankylosing Spondylitis
    HLA-DR4-Negative-Sjorgens Syndrome
    HLA-DR3-Negative-Rheumatoid Arthritis
    • 1Adm = Admission, 2Ref = Reference, 3Sed = Sedimentation, 4Anti-Nuclear Antibody

PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 30 (1)
American Society for Clinical Laboratory Science
Vol. 30, Issue 1
Winter 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Secondary (AA) Amyloidosis with Development of Nephrotic Syndrome
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Secondary (AA) Amyloidosis with Development of Nephrotic Syndrome
Christopher W. Larrimore, Ezra Fox
American Society for Clinical Laboratory Science Jan 2017, 30 (1) 23-27; DOI: 10.29074/ascls.30.1.23

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Secondary (AA) Amyloidosis with Development of Nephrotic Syndrome
Christopher W. Larrimore, Ezra Fox
American Society for Clinical Laboratory Science Jan 2017, 30 (1) 23-27; DOI: 10.29074/ascls.30.1.23
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • BACKGROUND
    • TREATMENT
    • CONCLUSION
    • ACKNOWLEDGEMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An Overview of Venous Blood Gas Analysis
  • Utility of Immunofixation as a Follow-up to Select Abnormal Serum Protein Electrophoresis Patterns and Suggestions for Clinical Correlation
  • Public Datasets: A Foundation to Artificial Intelligence in Health Care
Show more Clinical Practice

Similar Articles

Keywords

  • Systemic Amyloidosis
  • Inducible SAA
  • AA Amyloidosis

© 2026 The American Society for Clinical Laboratory Science

Powered by HighWire